Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread

The Lancet Infectious Diseases

Volumn 10, Issue 6, 2010, Pages 395-404

  Clements, Archie CA ^a,b   Magalhães, Ricardo J Soares ^a   Tatem, Andrew J ^c   Paterson, David L ^d   Riley, Thomas V ^e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ENVIRONMENTAL EXPOSURE; EPIDEMIC; FOOD; GEOGRAPHIC DISTRIBUTION; HUMAN; LIVESTOCK; MIGRATION; NONHUMAN; PATIENT TRANSPORT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ASIA; BACTERIAL TYPING TECHNIQUES; CENTRAL AMERICA; CLOSTRIDIUM DIFFICILE; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EUROPE; HUMANS; NORTH AMERICA; RIBOTYPING; RISK ASSESSMENT;

EID: 77952489657     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70080-3     Document Type: Review

References (150)

1. Larson H.E., Price A.B., Honour P., and Borriello S.P. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1 (1978) 1063-1066
2. Bartlett J.G., Moon N., Chang T.W., Taylor N., and Onderdonk A.B. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 75 (1978) 778-782
3. Thomas C., Stevenson M., and Riley T.V. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 51 (2003) 1339-1350
4. Chang V.T., and Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 31 (2000) 717-722
5. McFarland L.V., Surawicz C.M., and Stamm W.E. Risk factors for Clostridium difficile carriage and C difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 162 (1990) 678-684
6. Archibald L.K., Banerjee S.N., and Jarvis W.R. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 189 (2004) 1585-1589
7. Chandler R.E., Hedberg K., and Cieslak P.R. Clostridium difficile-associated disease in Oregon: increasing incidence and hospital-level risk factors. Infect Control Hosp Epidemiol 28 (2007) 116-122
8. Muto C.A., Pokrywka M., Shutt K., et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26 (2005) 273-280
9. Polk R.E., Oinonen M., and Pakyz A. Epidemic Clostridium difficile. N Engl J Med 354 (2006) 1199-1203
10. Vonberg R.P., Schwab F., and Gastmeier P. Clostridium difficile in discharged inpatients, Germany. Emerg Infect Dis 13 (2007) 179-180
11. Wilcox M.H., and Smyth E.T. Incidence and impact of Clostridium difficile infection in the UK, 1993-1996. J Hosp Infect 39 (1998) 181-187
12. McDonald L.C., Owings M., and Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 12 (2006) 409-415
13. Ricciardi R., Rothenberger D.A., Madoff R.D., and Baxter N.N. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 142 (2007) 624-631
14. Centers for Disease Control and Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 54 (2005) 1201-1205
15. Centers for Disease Control and Prevention. Surveillance for community-associated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep 57 (2008) 340-343
16. Benson L., Song X., Campos J., and Singh N. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 28 (2007) 1233-1235
17. Garey K.W., Jiang Z.D., Yadav Y., et al. Peripartum Clostridium difficile infection: case series and review of the literature. Am J Obstet Gynecol 199 (2008) 332-337
18. Hecker M.T., Riggs M.M., Hoyen C.K., Lancioni C., and Donskey C.J. Recurrent infection with epidemic Clostridium difficile in a peripartum woman whose infant was asymptomatically colonized with the same strain. Clin Infect Dis 46 (2008) 956-957
19. Rouphael N.G., O'Donnell J.A., Bhatnagar J., et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol 198 (2008) 635e1-e6.
20. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171 (2004) 466-472
21. Pépin J., Saheb N., Coulombe M.A., et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41 (2005) 1254-1260
22. Eggertson L. C difficile may have killed 2000 in Quebec: study. CMAJ 173 (2005) 1020-1021
23. Morris A.M., Jobe B.A., Stoney M., et al. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease?. Arch Surg 137 (2002) 1096-1100
24. Wysowski D.K. Increase in deaths related to enterocolitis due to Clostridium difficile in the United States, 1999-2002. Public Health Rep 121 (2006) 361-362
25. Zilberberg M.D., Shorr A.F., and Kollef M.H. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 14 (2008) 929-931
26. Redelings M.D., Sorvillo F., and Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 13 (2007) 1417-1419
27. Indra A., Huhulescu S., Kernbichler S., et al. First cases of Clostridium difficile PCR ribotype 027 acquired in Austria. Euro Surveill 13 (2008) 18875
28. Coignard B., Barbut F., Blanckaert K., et al. Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France, 2006. Euro Surveill 11 (2006) E060914 1.
29. Health Protection Agency. Outbreak of Clostridium difficile infection in a hospital in south east England. Commun Dis Rep Wkly 15 (2005) 2-3
30. Office for National Statistics. Deaths involving Clostridium difficile: England and Wales, 2001-2005. Health Stat Q 33 (2007) 71-75
31. Office for National Statistics. Deaths involving Clostridium difficile: England and Wales, 1999 and 2001-06. Health Stat Q 37 (2008) 52-56
32. Wilcox M. Clostridium difficile ribotyping network for England and Northern Ireland 2008/09 report (2009), Health Protection Agency, London
33. Centre for Infections Mandatory Surveillance Team. Summary points and commentary on quarterly (January 2006 to June 2008), calendar year (2004-2007) and financial year (2007/2008) Clostridium difficile data derived from Mandatory Surveillance, October 2008 (2008), Health Protection Agency, London
34. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353 (2005) 2433-2441
35. Loo V.G., Poirier L., Miller M.A., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353 (2005) 2442-2449
36. Smith A. Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxin-producing strains in Canada and the US. Euro Surveill 10 (2005) E050630 2.
37. Goorhuis A., Van der Kooi T., Vaessen N., et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 45 (2007) 695-703
38. van Steenbergen J., Debast S., van Kregten E., et al. Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C difficile-associated diarrhoea. Euro Surveill 10 (2005) E050714 1.
39. Kuijper E.J., van den Berg R.J., Debast S., et al. Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis 12 (2006) 827-830
40. Joseph R., Demeyer D., Vanrenterghem D., et al. First isolation of Clostridium difficile PCR ribotype 027, toxinotype III in Belgium. Euro Surveill 10 (2005) E051020 4.
41. Long S., Fenelon L., Fitzgerald S., et al. First isolation and report of clusters of Clostridium difficile PCR 027 cases in Ireland. Euro Surveill 12 (2007) E070426 3.
42. Tachon M., Cattoen C., Blanckaert K., et al. First cluster of C difficile toxinotype III, PCR-ribotype 027 associated disease in France: preliminary report. Euro Surveill 11 (2006) E060504 1.
43. Fenner L., Widmer A.F., Stranden A., et al. First cluster of clindamycin-resistant Clostridium difficile PCR ribotype 027 in Switzerland. Clin Microbiol Infect 14 (2008) 514-515
44. Kuijper E.J., Coignard B., Brazier J.S., et al. Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill 12 (2007) E1-E2
45. Kuijper E.J., Barbut F., Brazier J.S., et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 13 (2008) pii 18942
46. Kleinkauf N., Weiss B., Jansen A., et al. Confirmed cases and report of clusters of severe infections due to Clostridium difficile PCR ribotype 027 in Germany. Euro Surveill 12 (2007) E071115 2.
47. Zaiss N.H., Weile J., Ackermann G., et al. A case of Clostridium difficile-associated disease due to the highly virulent clone of Clostridium difficile PCR ribotype 027, March 2007 in Germany. Euro Surveill 12 (2007) E071115 1.
48. Indra A., Huhulescu S., Fiedler A., et al. Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009. Euro Surveill 14 (2009) pii 19186
49. Bacci S., St-Martin G., Olesen B., et al. Outbreak of Clostridium difficile 027 in North Zealand, Denmark, 2008-2009. Euro Surveill 14 (2009) pii 19186
50. Quesada-Gomez C., Rodriguez C., Mdel M.G.-C., et al. Emergence of Clostridium difficile NAP1 in Latin America. J Clin Microbiol 48 (2010) 669-670
51. Lukkarinen H., Eerola E., Ruohola A., et al. Clostridium difficile ribotype 027-associated disease in children with norovirus infection. Pediatr Infect Dis J 28 (2009) 847-848
52. Lyytikainen O., Mentula S., Kononen E., et al. First isolation of Clostridium difficile PCR ribotype 027 in Finland. Euro Surveill 12 (2007) E071108 2.
53. Terhes G., Urban E., Konkoly-Thege M., et al. First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary. Clin Microbiol Infect 15 (2009) 885-886
54. Baldan R., Cavallerio P., Tuscano A., et al. First report of hypervirulent strains polymerase chain reaction ribotypes 027 and 078 causing severe Clostridium difficile infection in Italy. Clin Infect Dis 50 (2010) 126-127
55. Ingebretsen A., Hansen G., Harmanus C., and Kuijper E.J. First confirmed cases of Clostridium difficile PCR ribotype 027 in Norway. Euro Surveill 13 (2008) pii 8011
56. Huang H., Weintraub A., Fang H., and Nord C.E. Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain. Scand J Infect Dis 41 (2009) 158-159
57. Riley T.V., Thean S., Hool G., and Golledge C.L. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med J Aust 190 (2009) 706-708
58. Tae C.H., Jung S.A., Song H.J., et al. The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. J Korean Med Sci 24 (2009) 520-524
59. Cheng V.C., Yam W.C., Chan J.F., et al. Clostridium difficile ribotype 027 arrives in Hong Kong. Int J Antimicrob Agents 34 (2009) 492-493
60. Kato H., Ito Y., van den Berg R.J., Kuijper E.J., and Arakawa Y. First isolation of Clostridium difficile 027 in Japan. Euro Surveill 12 (2007) E070111 3.
61. Sawabe E., Kato H., Osawa K., et al. Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period. Eur J Clin Microbiol Infect Dis 26 (2007) 695-703
62. Huang H., Weintraub A., Fang H., and Nord C.E. Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain. Scand J Infect Dis 41 (2009) 158-159
63. Miller M., Gravel D., Mulvey M., et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 50 (2010) 194-201
64. Barbut F., Mastrantonio P., Delmee M., et al. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13 (2007) 1048-1057
65. Labbe A.C., Poirier L., Maccannell D., et al. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 52 (2008) 3180-3187
66. Akerlund T., Persson I., Unemo M., et al. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol 46 (2008) 1530-1533
67. Warny M., Pepin J., Fang A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366 (2005) 1079-1084
68. Barbut F., Decre D., Lalande V., et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54 (2005) 181-185
69. Barbut F., Gariazzo B., Bonne L., et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 28 (2007) 131-139
70. Bourgault A.M., Lamothe F., Loo V.G., and Poirier L. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Quebec, Canada. Antimicrob Agents Chemother 50 (2006) 3473-3475
71. Hensgens M.P., Goorhuis A., Notermans D.W., van Benthem B.H., and Kuijper E.J. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill 14 (2009) pii 19402
72. Riley T.V. Epidemic Clostridium difficile. Med J Aust 185 (2006) 133-134
73. WHO. Principles and guidelines for the conduct of microbiological risk assessment (1999), World Health Organization, Geneva. http://www.who.int/foodsafety/publications/micro/cac1999/en/index.html (accessed April 22, 2010).
74. Vose D., Acar J., Anthony F., et al. Antimicrobial resistance: risk analysis methodology for the potential impact on public health of antimicrobial resistant bacteria of animal origin. Rev Sci Tech 20 (2001) 811-827
75. Alban L., Nielsen E.O., and Dahl J. A human health risk assessment for macrolide-resistant Campylobacter associated with the use of macrolides in Danish pig production. Prev Vet Med 83 (2008) 115-129
76. Bemrah N., Sanaa M., Cassin M.H., Griffiths M.W., and Cerf O. Quantitative risk assessment of human listeriosis from consumption of soft cheese made from raw milk. Prev Vet Med 37 (1998) 129-145
77. Bronsvoort B.M., Alban L., and Greiner M. Quantitative assessment of the likelihood of the introduction of classical swine fever virus into the Danish swine population. Prev Vet Med 85 (2008) 226-240
78. Follin P., Lindqvist A., Nystrom K., and Lindh M. A variety of respiratory viruses found in symptomatic travellers returning from countries with ongoing spread of the new influenza A(H1N1)v virus strain. Euro Surveill 14 (2009) pii 19242
79. Wilder-Smith A., Paton N.I., and Goh K.T. Experience of severe acute respiratory syndrome in singapore: importation of cases, and defense strategies at the airport. J Travel Med 10 (2003) 259-262
80. Hanna J.N., Ritchie S.A., Richards A.R., et al. Multiple outbreaks of dengue serotype 2 in north Queensland, 2003/04. Aust N Z J Public Health 30 (2006) 220-225
81. Johnson D.F., Druce J.D., Chapman S., et al. Chikungunya virus infection in travellers to Australia. Med J Aust 188 (2008) 41-43
82. Receveur M., Ezzedine K., Pistone T., and Malvy D. Chikungunya infection in a French traveller returning from the Maldives, October, 2009. Euro Surveill 15 (2010) 19494
83. Hanna J.N., Ritchie S.A., Eisen D.P., et al. An outbreak of Plasmodium vivax malaria in Far North Queensland, 2002. Med J Aust 180 (2004) 24-28
84. Riggs M.M., Sethi A.K., Zabarsky T.F., et al. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45 (2007) 992-998
85. McCoubrey J., Starr J., Martin H., and Poxton I.R. Clostridium difficile in a geriatric unit: a prospective epidemiological study employing a novel S-layer typing method. J Med Microbiol 52 (2003) 573-578
86. Viscidi R., Willey S., and Bartlett J.G. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81 (1981) 5-9
87. Beaugerie L., Flahault A., Barbut F., et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 17 (2003) 905-912
88. Songer J.G., Post K.W., Larson D.J., Jost B.H., and Glock R.D. Infection of neonatal swine with Clostridium difficile. Swine Health Prod 8 (2000) 185-189
89. Songer J.G. The emergence of Clostridium difficile as a pathogen of food animals. Anim Health Res Rev 5 (2004) 321-326
90. Waters E.H., Orr J.P., Clark E.G., and Schaufele C.M. Typhlocolitis caused by Clostridium difficile in suckling piglets. J Vet Diagn Invest 10 (1998) 104-108
91. Yaeger M., Funk N., and Hoffman L. A survey of agents associated with neonatal diarrhea in Iowa swine including Clostridium difficile and porcine reproductive and respiratory syndrome virus. J Vet Diagn Invest 14 (2002) 281-287
92. Baverud V., Gustafsson A., Franklin A., Aspan A., and Gunnarsson A. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet J 35 (2003) 465-471
93. Arroyo L.G., Staempfli H., and Weese J.S. Molecular analysis of Clostridium difficile isolates recovered from horses with diarrhea. Vet Microbiol 120 (2007) 179-183
94. Weese J.S., Finley R., Reid-Smith R.R., Janecko N., and Rousseau J. Evaluation of Clostridium difficile in dogs and the household environment. Epidemiol Infect (2009) 10.1017/S0950268809991312 published online Dec 2.
95. Goorhuis A., Bakker D., Corver J., et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47 (2008) 1162-1170
96. Arroyo L.G., Kruth S.A., Willey B.M., et al. PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J Med Microbiol 54 (2005) 163-166
97. Keel K., Brazier J.S., Post K.W., Weese S., and Songer J.G. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol 45 (2007) 1963-1964
98. Lefebvre S.L., Waltner-Toews D., Peregrine A.S., et al. Prevalence of zoonotic agents in dogs visiting hospitalized people in Ontario: implications for infection control. J Hosp Infect 62 (2006) 458-466
99. Rodriguez-Palacios A., Stampfli H.R., Duffield T., et al. Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis 12 (2006) 1730-1736
100. Lefebvre S.L., Arroyo L.G., and Weese J.S. Epidemic Clostridium difficile strain in hospital visitation dog. Emerg Infect Dis 12 (2006) 1036-1037
101. Songer J.G., Trinh H.T., Dial S.M., Brazier J.S., and Glock R.D. Equine colitis X associated with infection by Clostridium difficile NAP1/027. J Vet Diagn Invest 21 (2009) 377-380
102. Rodriguez-Palacios A., Staempfli H.R., Duffield T., and Weese J.S. Clostridium difficile in retail ground meat, Canada. Emerg Infect Dis 13 (2007) 485-487
103. Rodriguez-Palacios A., Reid-Smith R.J., Staempfli H.R., et al. Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg Infect Dis 15 (2009) 802-805
104. Songer J.G., Trinh H.T., Killgore G.E., et al. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis 15 (2009) 819-821
105. Weese J.S., Avery B.P., Rousseau J., and Reid-Smith R.J. Detection and enumeration of Clostridium difficile spores in retail beef and pork. Appl Environ Microbiol 75 (2009) 5009-5011
106. Weese J.S., Rousseau J., and Arroyo L. Bacteriological evaluation of commercial canine and feline raw diets. Can Vet J 46 (2005) 513-516
107. Bakri M.M., Brown D.J., Butcher J.P., and Sutherland A.D. Clostridium difficile in ready-to-eat salads, Scotland. Emerg Infect Dis 15 (2009) 817-818
108. Weese J.S. Clostridium difficile in food-innocent bystander or serious threat?. Clin Microbiol Infect 16 (2010) 3-10
109. Barbut F., Delmee M., Brazier J.S., et al. A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect 9 (2003) 989-996
110. Chen F., Chakera A., Seow C., et al. More on Clostridium diffcile-associated diarrhoea in Australia. Anaerobe 5 (1999) 205-207
111. Taylor J., Foster K., and Berrington A. Clostridium difficile: a questionnaire survey of laboratory practice in England, Wales, and Northern Ireland. Commun Dis Public Health 7 (2004) 322-327
112. Fitzpatrick F., Oza A., Gilleece A., O'Byrne A.M., and Drudy D. Laboratory diagnosis of Clostridium difficile-associated disease in the Republic of Ireland: a survey of Irish microbiology laboratories. J Hosp Infect 68 (2008) 315-321
113. Alfa M.J., Du T., and Beda G. Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. J Clin Microbiol 36 (1998) 2076-2080
114. Sohn S., Climo M., Diekema D., et al. Varying rates of Clostridium difficile-associated diarrhea at prevention epicenter hospitals. Infect Control Hosp Epidemiol 26 (2005) 676-679
115. Delmee M., Ramboer I., Van Broeck J., and Suetens C. Epidemiology of Clostridium difficile toxinotype III, PCR-ribotype 027 associated disease in Belgium, 2006. Euro Surveill 11 (2006) E060914 2.
116. Health Protection Agency. Surveillance of Clostridium difficile associated disease: report of the national standards group. CDR Weekly 40 (2003) 5-6
117. National Clostridium difficile Standards Group. National Clostridium difficile Standards Group: Report to the Department of Health. J Hosp Infect 56 suppl 1 (2004) 1-38
118. Donaldson L., and Beasley C. Letter from the Chief Medical Officer and Chief Nursing Officer: infection caused by Clostridium difficile (2005), Department of Health, London
119. Durai R. Epidemiology, pathogenesis, and management of Clostridium difficile infection. Dig Dis Sci 52 (2007) 2958-2962
120. Silversides A. Ontario's hospitals surpass those of Quebec in C difficile rates. CMAJ 178 (2008) 1649
121. Eggertson L., and Sibbald B. Need for national surveillance for hospital infections. CMAJ 171 (2004) 22
122. Department of Immigration and Citizenship. Annual Report 2007-08 (2008), Australian Government, Canberra. http://www.immi.gov.au/about/reports/annual/2007-08/ (accessed April 22, 2010).
123. Tatem A.J., and Hay S.I. Climatic similarity and biological exchange in the worldwide airline transportation network. Proc Biol Sci 274 (2007) 1489-1496
124. Fawley W.N., Parnell P., Verity P., Freeman J., and Wilcox M.H. Molecular epidemiology of endemic Clostridium difficile infection and the significance of subtypes of the United Kingdom epidemic strain (PCR ribotype 1). J Clin Microbiol 43 (2005) 2685-2696
125. Verity P., Wilcox M.H., Fawley W., and Parnell P. Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms. J Hosp Infect 49 (2001) 204-209
126. Samore M.H., Venkataraman L., DeGirolami P.C., Arbeit R.D., and Karchmer A.W. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 100 (1996) 32-40
127. Roberts K., Smith C.F., Snelling A.M., et al. Aerial dissemination of Clostridium difficile spores. BMC Infect Dis 8 (2008) 7
128. Starr J.M., and Campbell A. Mathematical modeling of Clostridium difficile infection. Clin Microbiol Infect 7 (2001) 432-437
129. Starr J.M., Campbell A., Renshaw E., Poxton I.R., and Gibson G.J. Spatio-temporal stochastic modelling of Clostridium difficile. J Hosp Infect 71 (2009) 49-56
130. Patrick D.M., Marra F., Hutchinson J., et al. Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe?. Clin Infect Dis 39 (2004) 11-17
131. Linder J.A., Huang E.S., Steinman M.A., Gonzales R., and Stafford R.S. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med 118 (2005) 259-268
132. Goossens H., Ferech M., Vander Stichele R., and Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 (2005) 579-587
133. Kazakova S.V., Ware K., Baughman B., et al. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 166 (2006) 2518-2524
134. McCusker M.E., Harris A.D., Perencevich E., and Roghmann M.C. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis 9 (2003) 730-733
135. McFarland L.V., Clarridge J.E., Beneda H.W., and Raugi G.J. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin Infect Dis 45 (2007) 1141-1151
136. Drudy D., Goorhuis B., Bakker D., et al. Clindamycin-resistant clone of Clostridium difficile PCR Ribotype 027, Europe. Emerg Infect Dis 14 (2008) 1485-1487
137. DeVincent S.J., and Viola C. Introduction to animal antimicrobial use data collection in the United States: methodological options. Prev Vet Med 73 (2006) 105-109
138. Viola C., and DeVincent S.J. Overview of issues pertaining to the manufacture, distribution, and use of antimicrobials in animals and other information relevant to animal antimicrobial use data collection in the United States. Prev Vet Med 73 (2006) 111-131
139. Ungemach F.R., Muller-Bahrdt D., and Abraham G. Guidelines for prudent use of antimicrobials and their implications on antibiotic usage in veterinary medicine. Int J Med Microbiol 296 suppl 41 (2006) 33-38
140. DeVincent S.J., and Viola C. Deliberations of an Advisory Committee regarding priorities, sources, and methods for collecting animal antimicrobial use data in the United States. Prev Vet Med 73 (2006) 133-151
141. Dubberke E.R., Reske K.A., Yan Y., et al. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45 (2007) 1543-1549
142. Biller P., Shank B., Lind L., et al. Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol 28 (2007) 198-201
143. Changela U., Cannon J.P., Aneziokoro C., et al. Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital. Int J Antimicrob Agents 24 (2004) 562-566
144. Dubberke E.R., Reske K.A., Olsen M.A., et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med 167 (2007) 1092-1097
145. Kyne L., Sougioultzis S., McFarland L.V., and Kelly C.P. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 23 (2002) 653-659
146. Modena S., Bearelly D., Swartz K., and Friedenberg F.K. Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study. Infect Control Hosp Epidemiol 26 (2005) 685-690
147. Palmore T.N., Sohn S., Malak S.F., Eagan J., and Sepkowitz K.A. Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol 26 (2005) 680-684
148. Pépin J., Valiquette L., and Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173 (2005) 1037-1042
149. Blossom D.B., and McDonald L.C. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis 45 (2007) 222-227
150. MacCannell D.R., Louie T.J., Gregson D.B., et al. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from eastern and western Canada. J Clin Microbiol 44 (2006) 2147-2152